Swelling controlled-release systems: recent developments and applications

International Journal of Pharmaceutics

Volumn 48, Issue 1-3, 1988, Pages 1-13

  Ranga Rao, K V ^a   Padmalatha Devi, K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Application in drug delivery; Cellulose ether; Ethylene vinyl alcohol; Hydrogel; Poly(ethylene oxide); Poly(hydroxyalkyl methacrylate); Poly(vinyl alcohol; Swelling controlled release system

Indexed keywords

BUNITROLOL; CELLULOSE DERIVATIVE; CINNARIZINE; COPOLYMER; DICLOFENAC; DIPROPHYLLINE; DOXORUBICIN; ETHYLENE VINYL ALCOHOL COPOLYMER; FLUOROURACIL; INDOMETACIN; LITHIUM CARBONATE; MACROGOL; MORPHINE; OXPRENOLOL; PHENYLPROPANOLAMINE; POLYMACON; POLYMER; POLYVINYL ALCOHOL; PREDNISOLONE; PREDNISONE; PROPRANOLOL; PROSTAGLANDIN E2; TEGAFUR; THEOPHYLLINE; THIAMINE;

ANIMAL EXPERIMENT; BIOAVAILABILITY; DRUG ANALYSIS; DRUG COMPARISON; DRUG DEVELOPMENT; DRUG RELEASE; EDEMA; HUMAN; HYDROGEL; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOLOGY; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; REVIEW; SUSTAINED RELEASE PREPARATION;

EID: 0023762939     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(88)90245-1     Document Type: Review

References (108)

1. Cross-lonked hydrophilic gels from ABA block copolymeric surfactants
2. Swelling and drug release from p-HEMA-MAA-hydrogel system
3. Physical model for release of drug from gel forming sustained release preparations
4. Sustained release tablet formulation of centperazine
5. Zero-order release hydrophilic matrix tablets of β-adrenergic blockers
6. Release characteristics of some bronchodilators from compressed hydrophilic polymeric matrices and their correlation with molecular geometry
7. Relationship between content and half-life of soluble β-blockers from hydrophilic matrix tablets
8. Controlled release drug delivery systems from hydrogels: Progesterone release from monolithic, reservoir, combined reservoir monolithic and monolithic devices with rate controlling barriers
9. Compressed polymeric minimatrices for drug release control
10. In vitro programmable zero-order release drug delivery system
11. Solute and penetrant diffusion in swellable polymers V. Relaxation-controlled transport in p (HEMA-co-MMA) copolymers
12. Water-swollen cellulose derivatives in pharmacy
13. The anomalous diffusion of propranolol hydrochloride through cross-linked poly HEMA films
14. Controlled release of antithrombotic agents from polymeric matrices
15. Influence of surfactants on drug release from hydroxypropylmethylcellulose matrices
16. Formulation of sustained release promethazine hydrochloride tablets using hydroxypropylmethylcellulose matrices
17. Propranolol hydrochloride and aminophylline release from matrix tablets containing hydroxypropylmethylcellulose
18. Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets
19. Matrici eterogenee di tiposwelling: proprieta fisiche e meccanismo di cessione
20. Kinetics and equilibria associated with the absorption of water and lithium chloride in an ethylene-vinyl alcohol copolymer
21. Matrices à libération contrôlée par le gonflement du polymère. Partie I: Mécanismes de pénétration des solvants dans les polymères
22. Matrices à libération contrôlée par le gonflement du polymère. Partie II: Préparation des systèmes médicamenteux et analyse de la cinétique de libération
23. Crosslinked polaxomers as a versatile drug delivery system
24. Cross-linked poly(alkylene oxides) for the preparation of controlled release formulations
25. Diffusion of water soluble drugs from initially dry hydrogels
26. Diffusion and localised swelling resistances in glassy polymers
27. Hydrogels in controlled drug delivery
28. Poly(ethylene oxide) and related hydrogels
29. Caffeine release from fully swollen poly(ethylene oxide) hydrogels
30. Preparation and characterisation of therapeutic hydrogels as oral dosage forms
31. Improving the release characteristics of water-soluble drugs from hydrophilic sustained release matrices by in situ gas generation
32. Controlled release from erodible slabs, cylinders and spheres
33. Factors affecting water sorption and solute release from glassy ethylene-vinyl alcohol copolymers
34. Controlled release of pilocarpine hydrochloride from ethylene-vinyl alcohol copolymer matrices
35. Conception and in vivo investigation of peroral sustained release floating dosage forms with enhanced gastrointestinal transit
36. Hydrogels for controlled drug release
37. Solute permeation through hydrogel membranes, Hydrophilic vs. hydrophobic solutes
38. Hydrophilic-hydrophobic balanced polymers for controlled delivery of drugs
39. Polymeric drug delivery systems
40. Hydrogels for encapsulations of pancreatic islet cells
41. Design of an ARA-A transdermal delivery system for animal studies: Regulation of drug concentration in vivo
42. Mechanisms of solute release from porous hydrophilic polymers
43. Solute and penetrant diffusion in swellable polymers. I. Mathematical modelling
44. Effect of the morphology of hydrophilic polymeric matrices on the diffusion and release of water soluble drugs
45. Macromolecular and modelling aspects of swelling-controlled systems
46. Transport phenomena in polymers. Diffusion and anomalous transport in glassy polymers
47. Solute and penetrant diffusion in swellable polymers. III. Drug release from glassy poly(HEMA-co-NVP) copolymers
48. Mechanism of drug release from a dynamically swelling hydrogel matrix
49. Release kinetics of indomethacin from polymeric matrices
50. Hydrogel delivery systems based on polymers alloys
51. Some chemically modified polaxomer hydrogels: preparation, morphology and swelling properties
52. Drug release from hydrogel devices with rate-controlling barriers
53. Diffusional release of a solute from a polymeric matrix—approximate analytical solutions
54. Dimentional changes during drug release from a glassy hydrogel matrix
55. Novel approach to zero-order drug delivery via immobilized nonuniform drug distribution in glassy hydrogels
56. Effect of non-uniform initial drug concentration on the kinetics of drug release from glassy hydrogel matrices
57. Kinetics of drug release from hydrogel matrices
58. Kinetics of drug-release from glassy polymers: effect of initially nonuniform drug distribution
59. Initial concentration distribution as a mechanism for regulating drug release from diffusion controlled and surface erosion controlled matrix systems
60. Interpretation of drug-release kinetics from hydrogel matrices in terms of time-dependent diffusion coefficients
61. Preparation and evaluation of intragastric floating preparations
62. Hydrogel diffusion and drug delivery systems
63. Biomedical applications of poly(2-hydroxyethyl methacrylate) and its copolymers
64. Morphine hydrogel suppositories: device design, scale-up and evaluation
65. A model for prediction of EGDMA-crosslinked pHEMA microparticles produced by suspension/copolymerisation/cross-linking
66. Preformulation of an Ara-A transdermal delivery system membrane fabrication and characterisation
67. Controlled drug release by ultrasound irradiation
68. Drug permeability of ethylene-vinyl alcohol copolymer membranes
69. Antitumor effect of implanted ethylene-vinyl alcohol copolymer matrices containing anticancer agents on Ehrlich ascites carcinoma and P388 leukemia in mice
70. Controlled release of anticancer agents through hydrophilic ethylene-vinyl alcohol copolymer membranes
71. Effect of implanted ethylene-vinyl alcohol copolymer matrices containing 5-flourouracil on Ehrlich ascites carcinoma
72. Rate-controlled rectal drug delivery system using PVA hydrogel
73. Evaluation of bunitrolol transdermal system using PVA hydrogel
74. Studies on Formulation of Sustained Release Dosage Forms of Some Beta Adrenergic Blockers
75. Comparison of pharmacokinetics of conventional and sustained release formulations of propranolol in fasted and fed dogs
76. Enzyme-digestible balloon hydrogels for long-term oral drug delivery: synthesis and characterization
77. Molecular surface areas and volumes and their use in structure/activity relationships
78. Hydrogels in biomedical applications
79. The swelling interface number as a criterion for prediction of diffusional solute release mechanisms in swellable polymers
80. Modelling of drug diffusion through swellable polymeric systems
81. Dynamically swelling hydrogels in controlled release applications
82. Hydrogels of poly(vinyl alcohol) and its copolymers
83. Structure and physical properties of poly(2-hydroxyethyl methacrylate) hydrogels
84. Influence of transverse differential swelling stress on the kinetics of sorption of penetrants by polymer membranes
85. The mechanism of interaction between chlorhexidine digluconate and poly(2-hydroxyethyl methacrylate)
86. Effect of a rate controlling membrane on release from polyHEMA hydrogels
87. Mode of solute release from cellulose matrices
88. Collagen-polyhydroxyethyl-methacrylate hydrogels: their in vivo biocompatibility
89. Biomedical applications of hydrogels: review a critical appraisal
90. A simple equation for description of solute release II Fickian and anomalous release from swellable devices
91. Synthetic hydrogels as drug delivery systems
92. Zero-order release of oxprenolol-HCl: a new approach
93. Zero-order release from hydrogels by controlled rupture formation
94. In-vitro and In-vivo performance of hydrophilic matrix tablets
95. Macromolecular diffusion through polymer membranes
96. Hydrogel drug delivery systems; physical and ionogenic drug carriers
97. Potential developments in hydrogel gastrointestinal delivery systems
98. Solute and penetrant diffusion in swellable polymers IV Semicrystalline swelling-controlled release systems of poly(ethylene-co-vinyl alcohol)
99. Mathematical simulation of anomalous transport: a generalised model for swelling controlled release systems
100. Herstellung von Acetylsalicylsäure Tabletten mit verzögerter Wirkstoffliberation auf der Basis hydrophiler Matrixformen
101. Zur Herstellung von retàrd formlingen auf der Basis hydrophiler Matrixformen mit Hilfe von Polyvinylalkohol
102. A theory of case II diffusion
103. Hydrophilic polyurethanes for the preparation of drug delivery systems
104. Studies on mechanism of drug release from hydrophilic monolithic delivery devices
105. A Deborah number for diffusion in polymer solvent systems
106. Controlled release by a combination chemical matrix
107. Permeation of water-soluble solutes through poly(2-hydroxyethyl methacrylate) and poly(2-hydroxyethyl methacrylate) crosslinked with ethylene glycol dimethacrylate